A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This protocol is a phase I/II, study of ascorbic acid (AA) infusions combined with treatment
with sorafenib versus treatment with sorafenib alone in subjects with metastatic
hepatocellular carcinoma. The phase I aspect will assess the safety and efficacy of the
concurrent treatments and the phase II aspect will utilize CT (computer-tomography) scans to
assess overall tumor response rate and evaluate disease progression